Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Sep 7, 2009

Scientists Use C. Crescentus to Make Proteins

  • Investigators at the University of British Columbia have figured out how to use Caulobacter crescentus to produce proteins. The scientists have developed a commercially available kit based on this technology.

    C. crescentus is a harmless bacterium that has a single protein layer on its surface. The research team changed the system that secretes this protein, which self-assembles into a structure called the S-layer. This adaptation led to the secretion of other proteins that are useful for vaccines and various therapeutic purposes, the scientists report.

    Additionally, by keeping the S-layer protein intact and instead genetically inserting new things, C. crescentus produced a dense display of useful proteins.

    “This S-layer system is very efficient at producing and secreting proteins—we can make the bacterium into a protein pump, secreting over half of all the protein it makes as an engineered S-layer protein,” says John Smit, Ph.D., who presented these findings at the Society for General Microbiology's meeting today.

    “Applications of S-layer display that we are currently developing include anticancer vaccines, an HIV infection blocker, and agents to treat Crohn's, colitis, and diarrhea in malnourished populations.”



Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »